Biotech NewsAstraZeneca (AZN) Targets $80 Billion Revenue by 2030 BioTech Health XOctober 14, 2025 AstraZeneca PLC (NASDAQ:AZN) is one of the world’s largest and most influential biopharmaceutical companies, built on a legacy… 0 Shares 0 0 0 0 0 0 0